Oncology therapeutics company scaling commercial and clinical operations
Menarini Stemline develops cancer treatments as a wholly-owned subsidiary of the Menarini Group. The tech stack reveals a commercial-first organization: heavy reliance on Veeva (CRM, Vault, Network, Link) for regulated pharma workflows, paired with Salesforce and modern data tools (Python, TensorFlow, Spark, Databricks). Sales hiring (19 open roles) dominates the org; the active project list—disease awareness, regional monitoring, in-label usage, CRM/Vault rollouts across EU and MEA—signals a scaling phase focused on geographic expansion and commercial execution rather than core R&D infrastructure.
Notable leadership hires: Marketing Director, Medical Director, Clinical Trial Lead
Menarini Stemline is the oncology-focused subsidiary of the Italian pharmaceutical and diagnostics conglomerate Menarini Group. The company discovers and develops cancer therapeutics targeting unmet medical needs. Operations span the United States and Europe (Austria, Poland, Slovakia, Czechia, UK, Italy, Belgium, Bulgaria) plus China and Malaysia. The organization is structured around commercial delivery: sales teams drive market access and in-label usage; healthcare, marketing, and finance teams support regional performance and payer navigation (including NHS-specific pathways). Active work includes CRM and Vault platform rollouts, patient journey mapping, scientific event organization, and key account planning.
Veeva (CRM, Vault, Network, Link), Salesforce, Python, R, TensorFlow, PyTorch, SQL, AWS, GCP, Databricks, and Apache Spark. The stack reflects pharmaceutical compliance workflows layered with modern data science tools.
Headquartered in New York. Active hiring and projects span the United States, EU (Austria, Poland, Slovakia, Czechia, UK, Italy, Belgium, Bulgaria), China, and Malaysia.
Other companies in the same industry, closest in size